TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

403 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Kidney disease

    Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis

    Testing amino acid supplements during hemodialysis for fatigue and thinking in end-stage kidney

    📍 The University of Texas Health Science Center at San Antonio · San Antonio, TX · Get directions →

    The study will test and compare the efficacy of a single essential amino acid valine with a combination of essential amino acids (EAA) supplement on fatigue, frailty, and cognitive function in end-stage kidney disease (ESKD) patients undergoing hemodialysis (HD) treatment.

    ✓ Study care freeEarly Phase 1Ages 18–64Learn more →
  • Kidney disease

    📍 Mayo Clinic in Arizona · Scottsdale, AZ · +4 more US sites · Get directions →

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-102 as a single agent and in combination with conventional anti-cancer drugs, pembrolizumab or trastuzumab deruxtecan(T-DXd) over a range of advanced and/or metastatic solid tumors.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Kidney disease

    A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

    Testing whether empagliflozin is safe and helps children with chronic kidney disease

    📍 University of Alabama at Birmingham · Birmingham, AL · +29 more US sites · Get directions →

    This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medicine called empagliflozin helps children and adolescents with CKD.

    ✓ Study care freePhase 3Ages 2–17Learn more →
  • Kidney disease

    Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

    Studying how blood vessel and nerve control during exercise works in people with chronic kidney

    📍 Emory Clinic · Atlanta, GA · +1 more US site · Get directions →

    The goals of this project are to investigate the mechanisms and potential therapies related to exercise capacity in persons with chronic kidney disease (CKD).

    ✓ Study care freePhase 2Ages 40–75Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

    Testing a remote mindful program to increase daily steps in people with COPD and heart failure

    📍 VA Boston · Boston, MA · +1 more US site · Get directions →

    The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF.

    ✓ Study care freeAges 40+Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Passive Heat Therapy for People With COPD

    Testing whether a 45-minute hot-water footbath improves blood flow in people with COPD

    📍 University of British Columbia · Kelowna, British Columbia · Get directions →

    People with Chronic Obstructive Pulmonary Disease (COPD) often develop high blood pressure and heart disease due to their sedentary lifestyle and difficulty exercising. The investigators will test if heating can mimic the health benefits of exercise by monitoring the increase in leg blood-flow using ultrasound during a 45-minute hot-water footbath.

    ✓ Study care freeAges 40+Learn more →
  • Type 2 diabetesKidney disease

    Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

    Testing insulin re-sensitization in people with type 2 diabetes and chronic kidney disease

    📍 Arizona Kidney Disease and Hypertension Center · Phoenix, AZ · Get directions →

    The purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).

    ✓ Study care freeAges 18+Learn more →
  • Kidney disease

    Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population

    Testing a noninvasive ear nerve stimulation device in people with chronic kidney disease

    📍 NYU Langone Health · New York, NY · Get directions →

    The purpose of this pilot interventional study is to collect preliminary data on the application of a transcutaneous auricular vagal nerve stimulation (taVNS) device in patients with chronic kidney disease (CKD). This data will enhance understanding of the short-term safety, tolerability and effects of this novel therapeutic approach in the setting of CKD.

    ✓ Study care freeAges 18–80Learn more →
  • Kidney disease

    Transitioning to Home or In-center Dialysis

    Comparing quality of life for people choosing home versus in-center dialysis for advanced kidney

    📍 Hôpital Maisonneuve-Rosemont · Montreal, Quebec · Get directions →

    For people with advanced kidney disease, deciding which type of dialysis is best can be challenging. Studies have shown that quality of life is very important to patients.

    ✓ Study care freeAges 18+Learn more →
  • Kidney disease

    Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)

    Testing a vein dilation device to help form an access for hemodialysis in kidney disease

    📍 Brigham Women's Hospital · Boston, MA · +1 more US site · Get directions →

    The AMPLIFI-1 Study is a prospective, multicenter pivotal clinical trial designed to evaluate the safety and effectiveness of the Amplifi™ Vein Dilation System in patients requiring distal arteriovenous fistula (AVF) creation for hemodialysis. The study has two cohorts: a randomized controlled (RC) cohort of patients with suitable cephalic veins (≥2.5 mm) randomized 2:1 to Amplifi treatment plus AVF creation versus standard AVF creation alone, and a non-randomized small vein cohort (NRC) of patients with borderline veins (1.7 to \<2.5 mm) treated with Amplifi therapy followed by AVF creation.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseDepression

    AI Platform for Fatigue and Depression Detection

    Testing how well an AI tool can spot fatigue and depression in heart patients

    📍 Indiana University · Indianapolis, IN · +1 more US site · Get directions →

    This observational study evaluates the accuracy of the Okaya AI platform in detecting fatigue and depression in cardiology patients, comparing its assessments to PHQ-9 and Fatigue Assessment Scale scores.

    ✓ Study care freeAges 18–99Learn more →
  • Kidney disease

    Lumbar Vein Embolization for Chronic Headaches With Nutcracker Physiology

    Studying whether blocking a lower back vein can treat chronic headaches

    📍 Mayo Clinic Florida · Jacksonville, FL · Get directions →

    The purpose of this research is to gather information on the safety and feasibility of coiling the lumbar vein for the treatment of chronic headaches in patients with Nutcracker physiology and retrograde lumbar vein flow with epidural venous plexus congestion. All patients are extensively evaluated by a headache trained Neurologist confirming high pressure headache refractory to other treatments.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    The Weight of Cardiovascular Disease

    Testing how a heart and metabolism clinic affects weight loss in obese adults with heart disease

    📍 Mayo Clinic in Rochester · Rochester, MN · Get directions →

    The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseKidney disease

    The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease

    Studying how kidney transplant affects tiny-heart-vessel blood flow in people with advanced chronic

    📍 Brigham and Women's Hospital · Boston, MA · Get directions →

    People with chronic kidney disease (CKD) often experience faster aging of the heart and blood vessels, which raises the risk of heart problems beyond traditional factors like high blood pressure or cholesterol. One early sign is reduced blood flow in the tiny vessels that supply the heart, measured by a positron emission tomography (PET) scan using a marker called myocardial flow reserve (MFR).

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Adapting and Testing a Novel Digital Health Tool (PREVENT) to Improve Health Behavior Counseling and Cardiovascular Health in Rural Primary Care Clinics

    Testing a digital health tool to improve weight and heart care talks in rural clinics

    📍 Washington University in St. Louis · St Louis, MO · Get directions →

    The focus on this application is low-income, rural patients, since cardiovascular disease (CVD) prevalence is 40% higher among rural than urban residents. Health behavior counseling and follow-up care are required for patients with an elevated body mass index who have increased risk for CVD.

    ✓ Study care freeAges 18–64Learn more →
  • Kidney disease

    Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

    Testing whether aiming for lower blood phosphate helps people with end-stage kidney disease

    📍 Royal Prince Alfred Hosptial · Camperdown, New South Wales · Get directions →

    During end-stage kidney disease, clinical guidelines suggest reducing elevated phosphate levels in the blood. However, the effect of lowering blood phosphate levels on important patient-centred outcomes has never been tested.

    ✓ Study care freeAges 18+Learn more →
  • High blood pressureKidney disease

    📍 Research Site · Surprise, AZ · +17 more US sites · Get directions →

    International, Multicenter and Double-Blind study. The purpose is to measure the effect of baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney disease and high blood pressure.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Kidney disease

    Precision Medicine Approaches to Renal Osteodystrophy

    Testing better ways to measure bone changes in people with chronic kidney disease

    📍 Washington University in St. Louis (WashU) · St Louis, MO · Get directions →

    Treatment of renal osteodystrophy is impeded by the lack of practical and accurate tools to determine underlying bone turnover. Gold standard bone biopsy is not practical in the clinic for the vast majority of kidney disease patients and parathyroid hormone and bone alkaline phosphatase have insufficient accuracy for turnover type to safely and confidently guide treatment of renal osteodystrophy.

    ✓ Study care freeAges 18+Learn more →
  • Lupus (SLE)

    Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

    Testing whether adding two lupus medicines to standard care improves kidney results

    📍 AARA Clinical Research · Glendale, AZ · +6 more US sites · Get directions →

    This is a Phase IV, open-label, randomized trial to determine whether the combination of Belimumab (BEL) and Voclosporin (VCS), plus background therapy with Mycophenolate Mofetil (MMF), improves the proportion of patients with proliferative lupus nephritis achieving complete renal response (CRR) compared to proportion of patients achieving CRR from recent clinical trials. This protocol will additionally determine whether combination therapy using Belimumab (BEL) and Voclosporin (VCS) facilitates rapid discontinuation of MMF.

    ✓ Study care freePhase 4Ages 18–80Learn more →
  • Kidney disease

    CommunityRx-Kidney Health

    Testing a new health information program to help manage kidney disease in rural North Carolina

    📍 Goshen Medical Center · Beulaville, NC · Get directions →

    In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effectiveness of CommunityRx-Kidney Health (CRx-K); this health information technology intervention integrates medical, social, and self-care resources to improve CKD management in rural eastern North Carolina.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure

    A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

    Testing a new digital tool doctors can use to prescribe exercise

    📍 UConn Health · Farmington, CT · +2 more US sites · Get directions →

    The investigators will conduct a feasibility and pilot efficacy randomized controlled trial to test the usability and user satisfaction of an evidence-based digital health tool the investigators developed for physicians to use to Prioritize Personalize Prescribe EXercise (P3-EX) to patients with cardiovascular disease (CVD) risk factors. The investigators will recruit 24 physicians from two local hospitals in CT, USA.

    ✓ Study care freeAges 18–64Learn more →
  • Heart / cardiovascular diseaseKidney disease

    A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

    Testing whether orforglipron changes heart outcomes in adults with heart disease and/or kidney

    📍 Instituto de Investigaciones Clínicas Bahia Blanca · Bahía Blanca, · Get directions →

    The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.

    ✓ Study care freePhase 3Ages 50+Learn more →
  • Kidney disease

    CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

    Comparing how two beta-blockers work in hemodialysis patients on heart outcomes

    📍 VA Long Beach Healthcare System, Long Beach, CA · Long Beach, CA · +7 more US sites · Get directions →

    The investigators aim to determine, using a point-of-care randomized controlled trial design, if hemodialysis patients, who are randomized to metoprolol succinate (a dialyzable, beta-1 selective beta blocker), have an improved cardiovascular outcome compared to those randomized to carvedilol (a non-dialyzable, non-selective beta blocker with alpha-1 antagonist properties). The investigators will also examine intervention practices to identify components that best support engagement and sustainability.

    ✓ Study care freePhase 3Ages 18+Learn more →
  • Kidney disease

    Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates

    Testing whether a 12-week virtual exercise and education program is feasible for people awaiting

    📍 Centre de recherche - Centre Hospitalier de l'Université de Montréal (CRCHUM) · Montreal, Quebec · Get directions →

    The goal of this RCT is to address the feasibility of conducting a 12-week virtual pre-habilitation intervention, which includes exercise and education, in kidney transplant candidates. The intervention also includes a 5-month maintenance phase with independent home exercises (maximum of 8 months of intervention/ended early if the participant undergoes a kidney transplant).

    ✓ Study care freeAges 18+Learn more →
  • Kidney disease

    The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients

    Testing a 12-week diabetes medicine combination in kidney transplant patients with kidney disease

    📍 Toronto General Hospital · Toronto, Ontario · Get directions →

    The study aims to determine the short-term efficacy, mechanisms and safety of 12 weeks of dapagliflozin and semaglutide combination therapy in 20 KTR, with and without T2D.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Lupus (SLE)

    📍 Investigative Site · Beverly Hills, CA · +9 more US sites · Get directions →

    The goal of this clinical trial is to learn if VENT-03 works to treat patients with cutaneous lupus erythematosus (CLE) who may or may not have systemic lupus erythematosus (SLE). Another goal is to learn about the safety of VENT-03 and how it is processed by the body.

    ✓ Study care freePhase 2Ages 18–80Learn more →
  • Lupus (SLE)Eczema / atopic dermatitis

    Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

    Testing whether baricitinib is safe in people with Job syndrome and lupus or eczema

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: Autosomal dominant hyper-IgE syndrome (HIES), also called Job syndrome, is a genetic disorder that affects the immune system. It can cause skin and lung infections and problems with blood vessels, connective tissues, and bones.

    ✓ Study care freePhase 1Ages 12–120Learn more →
  • Kidney disease

    Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD

    Testing whether empagliflozin changes kidney filter injury proteins in African American Veterans

    📍 Washington DC Veterans Affairs Medical Center (688) · Washington D.C., DC · Get directions →

    Primary Objective:To study podocyte specific injury markers in African American Veterans with non-diabetic kidney disease(NDKD), on empagliflozin therapy. Primary Endpoint: Assess the effect of Empagliflozin on podocyte-specific proteins in exosomes isolated from subjects' urine, such as nephrin, podocalyxin and Wilms'Tumor (WT-1) protein.

    ✓ Study care freePhase 4Ages 19–90Learn more →
  • Kidney disease

    Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease

    Testing how blood sugar level affects immune cell activation in people with type 1 diabetes and

    📍 Cleveland Clinic · Cleveland, OH · Get directions →

    This is a cross-sectional study in patients with Type 1 diabetes (TID) and chronic kidney disease (CKD) to test if time in range (TIR) affects the degree of hyperglycemia required for monocyte activation, podocyte injury, and assess if monocyte activation is attenuated by glucagon-like peptide (GLP-1) agonist treatment ex vivo.

    ✓ Study care freeAges 18–65Learn more →
  • Kidney disease

    Kidney Health: Eat Well, Live Well

    Testing a 6-month community program about diet for early kidney disease

    💵 May compensate

    📍 Harris Health System's Outpatient Center · Houston, TX · +2 more US sites · Get directions →

    This two-arm, parallel randomized trial study will assess the efficacy of a 6-month (26 weeks) community-based program in reducing kidney injury (as Urine Albumin to Creatinine ratio, uACR), cardiovascular risk (as Hemoglobin A1C and blood pressure), mental health (as PHQ-8) and diet quality (as fruits and vegetables intake and Healthy Eating Index) in community-dwelling, low-income adults diagnosed with early chronic kidney disease (stages 2 or 3 and not on kidney replacement therapies) compared to educational materials and usual care alone.

    ✓ Study care freeAges 18+Learn more →
  • Kidney disease

    Acute Equol Supplementation and Vascular Function in Women With and Without CKD

    Testing whether taking equol affects blood vessel function in women with or without CKD

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · Get directions →

    The risk of cardiovascular disease (CVD) is significantly elevated in patients with chronic kidney disease (CKD). Notably, women with CKD commonly experience menstrual disturbances induced by CKD, which may contribute to impaired vascular function and elevated CVD risk.

    ✓ Study care freePhase 2Ages 50–69WomenLearn more →
  • Lupus (SLE)

    CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

    Testing a cell therapy made from a person’s own immune cells for lupus

    📍 Children's Hospital of Philadelphia · Philadelphia, PA · Get directions →

    This is a single-center, single-arm, open-label phase 1/2 study of CART19 in children and young adults with refractory Systemic lupus erythematosus (SLE), including both patients diagnosed with lupus nephritis (LN) and patients with non-renal Systemic lupus erythematosus (SLE). Phase 1 will evaluate the safety of CART19 in 6-12 patients with Systemic lupus erythematosus (SLE).

    ✓ Study care freePhase 1Ages 12–29Learn more →
  • Heart / cardiovascular diseaseDepressionAnxiety

    Improving Care and Mental Well-Being for Adults With Heart Failure

    Testing ways to improve mental well-being for adults with heart failure

    📍 Seaway Valley Community Health Centre (Cardiac Rehab Program) · Cornwall, Ontario · Get directions →

    Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives.

    ✓ Study care freeAges 40+Learn more →
  • Lupus (SLE)

    US Zamto-cel Autoimmune Diseases

    Testing the safety of an experimental cell therapy for lupus

    📍 Froedtert Hospital and the Medical College of Wisconsin · Milwaukee, WI · Get directions →

    AID is a phase I multi-cohort study to assess the safety and tolerability of zamtocabtagene autoleucel (zamto-cel) in patients with refractory autoimmune diseases (SLE-Non renal, SLE-LN, SSc/dcSSc) after receiving standard therapy.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Lupus (SLE)

    Dapagliflozin in Active Lupus Nephritis

    Testing dapagliflozin for lupus-related kidney inflammation (kidney disease)

    📍 Massachusetts General Hospital · Boston, MA · +1 more US site · Get directions →

    Lupus nephritis is a chronic and life-threatening autoimmune cause of kidney disease that predominately impacts young people and can lead to kidney failure. Sodium-glucose co-transporter-2 inhibitors, including dapagliflozin, are known to improve outcomes for people with other causes of chronic kidney disease.

    ✓ Study care freePhase 4Ages 18–70Learn more →
  • Kidney disease

    📍 SouthCoast Research Center, Inc. · Miami, FL · +1 more US site · Get directions →

    The goal of this clinical trial is to learn about the safety (good or bad) of giving two AION-301 intravenous (IV) infusions, in adults with Stage 3 Chronic Kidney Disease (CKD). It will also help to learn if AION-301 reduces the symptoms of CKD and/or progression.

    ✓ Study care freePhase 1Ages 35–75Learn more →
  • Lupus (SLE)

    A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

    Testing enpatoran over 24 weeks for skin lupus symptoms, with or without whole-body disease

    📍 Inland Rheumatology Clinical Trials, Inc. · Upland, CA · +7 more US sites · Get directions →

    The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include: Study Duration: Up to 35 weeks.

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Lupus (SLE)

    A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

    Testing the safety and early effects of a new treatment for lupus in adults

    📍 Research Site 4 · Redwood City, CA · +6 more US sites · Get directions →

    This is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune diseases, including active systemic lupus erythematosus (SLE), systemic sclerosis (SSc), or idiopathic inflammatory myopathy (IIM).

    ✓ Study care freePhase 1Ages 18–70Learn more →
  • Kidney disease

    Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

    Testing whether stem cells from bone marrow are safe in people with chronic kidney disease,

    📍 Mayo Clinic · Jacksonville, FL · Get directions →

    The purpose of this protocol is to treat an intermediate-sized population with chronic kidney disease (CKD) including kidney transplant recipients. The protocol uses allogeneic bone marrow-derived mesenchymal stem cells (MSCs).

    ✓ Study care freeAges 18+Learn more →
  • Kidney disease

    Intradialytic Exercise Combined With Creatine Monohydrate in Patients With Chronic Kidney Disease Undergoing Hemodialysis.

    Testing whether exercise during dialysis and creatine help people with chronic kidney disease

    📍 IMSS-Bienestar State Haemodialysis Centre · Colima, Coliima · Get directions →

    This study aims to evaluate the effects of creatine monohydrate supplementation and an intradialytic exercise program on body composition, biochemical parameters, and functional capacity in patients with chronic kidney disease (CKD) undergoing maintenance hemodialysis. The study will compare the independent and combined effects of these interventions over an 8-week period to determine their potential benefits in this patient population.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time

    Testing home tools and wearable devices to reduce health harms from evening screen time in people

    📍 Arizona State University · Tempe, AZ · Get directions →

    The purpose of this study is to determine the feasibility, acceptability, efficacy, and participant adherence in using home-based technologies and wearable devices and simple, practical strategies to reduce the negative impact that evening screen time may have on your health.

    ✓ Study care freeAges 26+Learn more →
  • Lupus (SLE)

    INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

    Studying how adding anifrolumab to usual care affects lupus in real life

    💵 May compensate

    📍 Research Site · Buenos Aires, · Get directions →

    INTERSTELLAR study will generate critical prospective real-world evidence on the benefits of adding Anifrolumab to standard of care treatment for SLE in routine clinical practice, to inform physicians, payers and patients. The study will use clinical assessments that are relevant for SLE-treating physicians in routine clinical practice, as well as introduce a specific measure for skin manifestations to affirm the potency of anifrolumab in treating SLE-related skin manifestations.

    ✓ Study care freeAges 18+Learn more →
  • Lupus (SLE)Rheumatoid arthritisMultiple sclerosis (MS)

    A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

    Tracking long-term side effects and persistence after gene-edited CAR T treatment for lupus,

    📍 University of Colorado, Denver · Denver, CO · Get directions →

    The purpose of this long-term follow-up (LTFU) study is to collect delayed adverse events (AEs) and understand the persistence of KYV-101 (autologous CAR T cell product; gene-modified product), in participants who have been administered KYV-101 (gene-modified product; autologous CAR T cell product). This LTFU protocol will be open to any participant who received at least one infusion of KYV-101 in a previous Kyverna sponsored clinical trial or Investigator Initiated Trial (IIT).

    ✓ Study care freeAges 18+Learn more →
  • Lupus (SLE)

    A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

    Testing the safety and tolerance of budoprutug in adults with lupus

    📍 Climb Bio Investigative Site #100104 · Allen, TX · +1 more US site · Get directions →

    The main objective is to assess the safety and tolerability of budoprutug in adults with SLE. Pharmacokinetics, pharmacodynamics, and preliminary clinical efficacy will also be assessed.

    ✓ Study care freePhase 1Ages 18–65Learn more →
  • Kidney disease

    Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

    Testing kidney disease drug effects and safety in teens with early CKD

    💵 May compensate

    📍 Instituto de atención Integral de Enfermedades Renales del Estado de Aguascalientes · Aguascalientes, Aguascalientes · Get directions →

    Chronic kidney disease (CKD) is highly prevalent in the state of Aguascalientes, Mexico, particularly among adolescents and young adults. Epidemiologic and histologic studies suggest that this burden is largely driven by reduced nephron endowment of prenatal origin, leading to compensatory glomerular hyperfiltration, adaptive podocytopathy, and persistent albuminuria at early stages of disease.

    ✓ Study care freePhase 4Ages 14–18Learn more →
  • Kidney disease

    The Use of AR / VR in Patients Presenting to the ED With Renal Colic

    Testing virtual or augmented reality calming to help manage pain from kidney stone colic in the

    📍 Rutgers Robert Wood Johnson Barnabas Health Community Medical Center · Toms River, NJ · Get directions →

    Utilization of VR / AR Calming as an adjunct to pharmacologic pain management for Renal Colic in Emergency Department Patients

    ✓ Study care freeAges 18+Learn more →
  • Type 2 diabetesHeart / cardiovascular disease

    Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

    Testing how drinking ketone drinks affects heart function in people with type 2 diabetes and heart

    📍 University of Texas Health Science Center at San Antonio · San Antonio, TX · Get directions →

    This study will provide insight into whether cardiac function changes with oral Ketone Esters (KE) administered to patients with Type 2 Diabetes Mellitus (T2DM) and Heart failure with reduced ejection fraction (HFrEF). Plasma ketones are avidly extracted by cardiac muscle and their uptake is not dependent upon insulin or influenced by insulin resistance.

    ✓ Study care freeEarly Phase 1Ages 18–80Learn more →
  • Lupus (SLE)

    A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

    Testing whether different doses of BI 3000202 help adults with lupus

    📍 Wallace & Lee Center · Beverly Hills, CA · +29 more US sites · Get directions →

    This study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps people with SLE.

    ✓ Study care freePhase 2Ages 18–74Learn more →
  • Lupus (SLE)

    Systemic Lupus Erythematosus in Gullah Health

    Studying lupus health in Gullah people

    📍 Medical University of South Carolina · Charleston, SC · Get directions →

    Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies, multiple organ involvement, and diverse clinical symptoms and immunologic manifestations. African Americans are at a disproportionately higher risk of developing SLE, develop SLE at an earlier age, and have increased morbidity and mortality compared with European Americans.

    ✓ Study care freeAges 2+Learn more →
  • Lupus (SLE)

    Research Accelerated by You Lupus Registry

    A remote study registry to learn about lupus diagnosis, care, and life quality

    📍 Online Registry - No Physical Site Required · Washington D.C., DC · Get directions →

    Summary The Lupus Foundation of America (LFA) Research Accelerated by You (RAY) Registry is a fully remote, longitudinal registry designed to collect data from adults and children living with lupus. The primary goal is to better understand the diagnosis, treatment, care, and quality of life for those affected by the disease.

    ✓ Study care freeLearn more →
  • Lupus (SLE)

    Cutaneous Lupus Registry

    Building a registry to study skin lupus in people with and without lupus

    📍 University of Texas Southwestern Medical Center Dallas · Dallas, TX · Get directions →

    Approximately 1.4 million individuals in the United States have systemic lupus erythematosus, and about 85% of these individuals develop skin lesions at some point of their disease. Cutaneous lupus erythematosus represents the skin manifestations of systemic lupus erythematosus, and can appear in people with or without systemic lupus.

    ✓ Study care freeAges 18+Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

    Testing a CD19-targeted CAR T cell treatment in people with severe lupus or rheumatoid arthritis

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · +30 more US sites · Get directions →

    The purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refractory autoimmune diseases (Breakfree-1).

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    New Heart Imaging Techniques to Evaluate Possible Heart Disease

    Testing new heart imaging to check for possible heart disease

    💵 May compensate

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: \- Imaging tests, such as magnetic resonance imaging (MRI), can provide information about heart and blood vessels. The tests let doctors can see the amount of blood vessel narrowing and vessel wall thickness.

    ✓ Study care freeAges 18–100Learn more →
  • High blood pressureKidney disease

    KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)

    Looking at kidney health and blood pressure outcomes in survivors of childhood cancer

    📍 The Hospital For Sick Children · Toronto, Ontario · Get directions →

    Background: Childhood cancer survivors (CCS) are at elevated risk of chronic health conditions. Chemotherapies can cause recurrent acute kidney injury which may progress to kidney fibrosis, chronic kidney disease (CKD) or hypertension (HTN).

    ✓ Study care freeLearn more →
  • Lupus (SLE)

    A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

    Testing current treatment options for active lupus that did not respond

    📍 Local Institution - 0062 · Mesa, AZ · +24 more US sites · Get directions →

    The purpose of this study is to characterize the efficacy and safety of current standard of care treatment options in participants with active systemic lupus erythematosus (SLE; including lupus nephritis) with inadequate response to glucocorticoids and at least two immunosuppressants

    ✓ Study care freeAges 16+Learn more →
  • Kidney disease

    Randomised Evaluation of Sodium Dialysate Levels on Vascular Events

    Testing whether two dialysate salt levels affect heart events and death

    📍 Royal Adelaide Hospital · Adelaide, · Get directions →

    This global study will assess the effect of randomising dialysis sites to one of two default dialysate sodium concentrations in current practice, 140mmol/l and 137mmol/l, on major cardiovascular events and death in patients receiving maintenance haemodialysis.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Lupus (SLE)

    Brief Pain Exposure Therapy (BPET) For Nociplastic Pain

    Testing a short Zoom-based therapy to help adults with lupus learn pain coping skills

    📍 University of Michigan · Ann Arbor, MI · Get directions →

    This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia (FM), Lupus, chronic pelvic pain, and chronic low back pain learn effective strategies for reducing pain, disability and other problems that can come with fibromyalgia, Lupus, chronic pelvic pain, and chronic low back pain (such as depression or anxiety).

    ✓ Study care freeAges 18+Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    Maternal Autoimmune Disease Research Alliance (MADRA) Registry

    Tracking pregnant people with lupus or rheumatoid arthritis

    📍 Duke University · Durham, NC · Get directions →

    This multi-site registry, centered at Duke University, will enroll pregnant women with autoimmune and rheumatologic diseases. The main goal of MADRA is to identify ways to improve the health of women with rheumatic diseases and their babies during pregnancy.

    ✓ Study care freeWomenLearn more →
  • Lupus (SLE)

    Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

    Testing a 1.5% ruxolitinib cream for discoid lupus in adults

    📍 INNO-6051 Site 03 · Fredericton, New Brunswick · Get directions →

    This study is a single-blind, intraindividual study to evaluate the efficacy of ruxolitinib 1.5 % cream in adult subjects with discoid lupus erythematosus.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Heart / cardiovascular diseaseKidney diseaseCOPD (chronic lung disease)

    Home Hospital for Suddenly Ill Adults

    Testing home-based care for suddenly ill adults with heart, lung, or kidney conditions

    📍 Brigham and Women's Hospital · Boston, MA · +1 more US site · Get directions →

    The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.

    ✓ Study care freeAges 18+Learn more →
  • Showing the first 60 of 403. Add filters or a location to narrow down.